☰

Alison P. Galvani - Publications

Affiliations: 
Yale University, New Haven, CT 
Area:
Epidemiology
Tree Info Similar researchers PubMed Report error

151 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2023 Laufer RS, Baral R, Buchwald AG, Campbell JD, Coulibaly F, Diallo F, Doumbia M, Driscoll AJ, Galvani AP, Keita AM, Neuzil KM, Sow S, Pecenka C, Ortiz JR, Fitzpatrick MC. Optimizing next-generation RSV prevention in Mali: A cost-effectiveness analysis of pediatric vaccination, maternal vaccination, and extended half-life monoclonal antibody immunoprophylaxis. Plos Global Public Health. 3: e0001432. PMID 37145993 DOI: 10.1371/journal.pgph.0001432  0.303
2022 Wells CR, Pandey A, Gokcebel S, Krieger G, Donoghue AM, Singer BH, Moghadas SM, Galvani AP, Townsend JP. Quarantine and serial testing for variants of SARS-CoV-2 with benefits of vaccination and boosting on consequent control of COVID-19. Pnas Nexus. 1: pgac100. PMID 35909795 DOI: 10.1093/pnasnexus/pgac100  0.321
2020 Moghadas SM, Vilches TN, Zhang K, Wells CR, Shoukat A, Singer BH, Meyers LA, Neuzil KM, Langley JM, Fitzpatrick MC, Galvani AP. The impact of vaccination on COVID-19 outbreaks in the United States. Medrxiv : the Preprint Server For Health Sciences. PMID 33269359 DOI: 10.1101/2020.11.27.20240051  0.308
2020 Wang X, Du Z, Huang G, Pasco RF, Fox SJ, Galvani AP, Pignone M, Johnston SC, Meyers LA. Effects of Cocooning on Coronavirus Disease Rates after Relaxing Social Distancing. Emerging Infectious Diseases. 26. PMID 32956613 DOI: 10.3201/Eid2612.201930  0.302
2020 Moghadas SM, Fitzpatrick MC, Sah P, Pandey A, Shoukat A, Singer BH, Galvani AP. The implications of silent transmission for the control of COVID-19 outbreaks. Proceedings of the National Academy of Sciences of the United States of America. PMID 32632012 DOI: 10.1073/Pnas.2008373117  0.329
2020 Du Z, Nugent C, Galvani AP, Krug RM, Meyers LA. Modeling mitigation of influenza epidemics by baloxavir. Nature Communications. 11: 2750. PMID 32487990 DOI: 10.1038/S41467-020-16585-Y  0.334
2020 Wells CR, Huppert A, Fitzpatrick MC, Pandey A, Velan B, Singer BH, Bauch CT, Galvani AP. Prosocial polio vaccination in Israel. Proceedings of the National Academy of Sciences of the United States of America. PMID 32457142 DOI: 10.1073/Pnas.1922746117  0.407
2020 Alfaro-Murillo JA, Ávila-Agüero ML, Fitzpatrick MC, Crystal CJ, Falleiros-Arlant LH, Galvani AP. The case for replacing live oral polio vaccine with inactivated vaccine in the Americas. Lancet (London, England). 395: 1163-1166. PMID 32247397 DOI: 10.1016/S0140-6736(20)30213-0  0.384
2020 Wells CR, Sah P, Moghadas SM, Pandey A, Shoukat A, Wang Y, Wang Z, Meyers LA, Singer BH, Galvani AP. Impact of international travel and border control measures on the global spread of the novel 2019 coronavirus outbreak. Proceedings of the National Academy of Sciences of the United States of America. PMID 32170017 DOI: 10.1073/Pnas.2002616117  0.318
2020 Champredon D, Shoukat A, Singer BH, Galvani AP, Moghadas SM. Curbing the 2019 Samoa measles outbreak. The Lancet. Infectious Diseases. 20: 287-288. PMID 32112762 DOI: 10.1016/S1473-3099(20)30044-X  0.344
2020 Castaño MS, Ndeffo-Mbah ML, Rock KS, Palmer C, Knock E, Miaka EM, Ndung’u JM, Torr S, Verlé P, Spencer SEF, Galvani A, Bever C, Keeling MJ, Chitnis N. Assessing the impact of aggregating disease stage data in model predictions of human African trypanosomiasis transmission and control activities in Bandundu province (DRC). Plos Neglected Tropical Diseases. 14. DOI: 10.1371/Journal.Pntd.0007976  0.336
2019 Ndeffo-Mbah ML, Pandey A, Atkins KE, Aksoy S, Galvani AP. The impact of vector migration on the effectiveness of strategies to control gambiense human African trypanosomiasis. Plos Neglected Tropical Diseases. 13: e0007903. PMID 31805051 DOI: 10.1371/Journal.Pntd.0007903  0.304
2019 Wells CR, Pandey A, Ndeffo Mbah ML, Gaüzère BA, Malvy D, Singer BH, Galvani AP. The exacerbation of Ebola outbreaks by conflict in the Democratic Republic of the Congo. Proceedings of the National Academy of Sciences of the United States of America. PMID 31636188 DOI: 10.1073/Pnas.1913980116  0.409
2019 Sah P, Alfaro-Murillo JA, Fitzpatrick MC, Neuzil KM, Meyers LA, Singer BH, Galvani AP. Future epidemiological and economic impacts of universal influenza vaccines. Proceedings of the National Academy of Sciences of the United States of America. PMID 31548402 DOI: 10.1073/Pnas.1909613116  0.422
2019 Fitzpatrick MC, Bauch CT, Townsend JP, Galvani AP. Modelling microbial infection to address global health challenges. Nature Microbiology. 4: 1612-1619. PMID 31541212 DOI: 10.1038/S41564-019-0565-8  0.353
2019 Beyene TJ, Fitzpatrick MC, Galvani AP, Mourits MCM, Revie CW, Cernicchiaro N, Sanderson MW, Hogeveen H. Impact of One-Health framework on vaccination cost-effectiveness: A case study of rabies in Ethiopia. One Health (Amsterdam, Netherlands). 8: 100103. PMID 31528684 DOI: 10.1016/J.Onehlt.2019.100103  0.44
2019 Wells CR, Pandey A, Parpia AS, Fitzpatrick MC, Meyers LA, Singer BH, Galvani AP. Ebola vaccination in the Democratic Republic of the Congo. Proceedings of the National Academy of Sciences of the United States of America. PMID 31036657 DOI: 10.1073/Pnas.1817329116  0.427
2019 Capewell P, Atkins K, Weir W, Jamonneau V, Camara M, Clucas C, Swar NK, Ngoyi DM, Rotureau B, Garside P, Galvani AP, Bucheton B, MacLeod A. Resolving the apparent transmission paradox of African sleeping sickness. Plos Biology. 17: e3000105. PMID 30633739 DOI: 10.1371/Journal.Pbio.3000105  0.309
2018 Bartsch SM, Asti L, Cox S, Durham DP, Randall S, Hotez PJ, Galvani AP, Lee BY. What is the Value of Different Zika Vaccination Strategies to Prevent and Mitigate Zika Outbreaks. The Journal of Infectious Diseases. PMID 30544164 DOI: 10.1093/Infdis/Jiy688  0.392
2018 Galvani AP, Pandey A, Fitzpatrick MC, Medlock J, Gray GE. Defining control of HIV epidemics. The Lancet. Hiv. PMID 30314745 DOI: 10.1016/S2352-3018(18)30178-4  0.31
2018 Medley GF, Blok DJ, Crump RE, Hollingsworth TD, Galvani AP, Ndeffo-Mbah ML, Porco TC, Richardus JH. Policy Lessons From Quantitative Modeling of Leprosy. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. 66: S281-S285. PMID 29860289 DOI: 10.1093/Cid/Ciy005  0.338
2018 Sah P, Medlock J, Fitzpatrick MC, Singer BH, Galvani AP. Optimizing the impact of low-efficacy influenza vaccines. Proceedings of the National Academy of Sciences of the United States of America. PMID 29712866 DOI: 10.1073/Pnas.1802479115  0.4
2018 Durham DP, Fitzpatrick MC, Ndeffo-Mbah ML, Parpia AS, Michael NL, Galvani AP. Evaluating Vaccination Strategies for Zika Virus in the Americas. Annals of Internal Medicine. PMID 29610863 DOI: 10.7326/M17-0641  0.381
2018 Ndeffo-Mbah ML, Vigliotti VS, Skrip LA, Dolan K, Galvani AP. Dynamic Models of Infectious Disease Transmission in Prisons and the General Population. Epidemiologic Reviews. PMID 29566137 DOI: 10.1093/Epirev/Mxx014  0.355
2018 Lee BY, Bartsch SM, Skrip L, Hertenstein DL, Avelis CM, Ndeffo-Mbah M, Tilchin C, Dumonteil EO, Galvani A. Are the London Declaration's 2020 goals sufficient to control Chagas disease?: Modeling scenarios for the Yucatan Peninsula. Plos Neglected Tropical Diseases. 12: e0006337. PMID 29554086 DOI: 10.1371/Journal.Pntd.0006337  0.31
2017 Alsallaq RA, Gurarie D, Ndeffo Mbah M, Galvani A, King C. Quantitative assessment of the impact of partially protective anti-schistosomiasis vaccines. Plos Neglected Tropical Diseases. 11: e0005544. PMID 28410369 DOI: 10.1371/Journal.Pntd.0005544  0.399
2017 Skrip LA, Fallah MP, Gaffney SG, Yaari R, Yamin D, Huppert A, Bawo L, Nyenswah T, Galvani AP. Characterizing risk of Ebola transmission based on frequency and type of case-contact exposures. Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences. 372. PMID 28396472 DOI: 10.1098/Rstb.2016.0301  0.35
2017 Medlock J, Pandey A, Parpia AS, Tang A, Skrip LA, Galvani AP. Effectiveness of UNAIDS targets and HIV vaccination across 127 countries. Proceedings of the National Academy of Sciences of the United States of America. PMID 28320938 DOI: 10.1073/Pnas.1620788114  0.384
2017 Bartsch SM, Peterson JK, Hertenstein DL, Skrip L, Ndeffo-Mbah M, Galvani AP, Dobson AP, Lee BY. Comparison and validation of two computational models of Chagas disease: A thirty year perspective from Venezuela. Epidemics. 18: 81-91. PMID 28279459 DOI: 10.1016/J.Epidem.2017.02.004  0.303
2017 Rock KS, Pandey A, Ndeffo-Mbah ML, Atkins KE, Lumbala C, Galvani A, Keeling MJ. Data-driven models to predict the elimination of sleeping sickness in former Equateur province of DRC. Epidemics. 18: 101-112. PMID 28279451 DOI: 10.1016/J.Epidem.2017.01.006  0.356
2016 Fitzpatrick MC, Shah HA, Pandey A, Bilinski AM, Kakkar M, Clark AD, Townsend JP, Abbas SS, Galvani AP. One Health approach to cost-effective rabies control in India. Proceedings of the National Academy of Sciences of the United States of America. PMID 27994161 DOI: 10.1073/Pnas.1604975113  0.382
2016 Galvani AP, Bauch CT, Anand M, Singer BH, Levin SA. Human-environment interactions in population and ecosystem health. Proceedings of the National Academy of Sciences of the United States of America. PMID 27956616 DOI: 10.1073/Pnas.1618138113  0.307
2016 Gilbert JA, Shenoi SV, Moll AP, Friedland GH, Paltiel AD, Galvani AP. Cost-Effectiveness of Community-Based TB/HIV Screening and Linkage to Care in Rural South Africa. Plos One. 11: e0165614. PMID 27906986 DOI: 10.1371/Journal.Pone.0165614  0.314
2016 Schlüter DK, Ndeffo-Mbah ML, Takougang I, Ukety T, Wanji S, Galvani AP, Diggle PJ. Using Community-Level Prevalence of Loa loa Infection to Predict the Proportion of Highly-Infected Individuals: Statistical Modelling to Support Lymphatic Filariasis and Onchocerciasis Elimination Programs. Plos Neglected Tropical Diseases. 10: e0005157. PMID 27906982 DOI: 10.1371/Journal.Pntd.0005157  0.31
2016 Bilinski AM, Fitzpatrick MC, Rupprecht CE, Paltiel AD, Galvani AP. Optimal frequency of rabies vaccination campaigns in Sub-Saharan Africa. Proceedings. Biological Sciences. 283. PMID 27852799 DOI: 10.1098/Rspb.2016.1211  0.422
2016 Yamin D, Jones FK, DeVincenzo JP, Gertler S, Kobiler O, Townsend JP, Galvani AP. Vaccination strategies against respiratory syncytial virus. Proceedings of the National Academy of Sciences of the United States of America. PMID 27799521 DOI: 10.1073/Pnas.1522597113  0.412
2016 Yamin D, Atkins KE, Remy V, Galvani AP. Cost-Effectiveness of Rotavirus Vaccination in France-Accounting for Indirect Protection. Value in Health : the Journal of the International Society For Pharmacoeconomics and Outcomes Research. 19: 811-819. PMID 27712709 DOI: 10.1016/J.Jval.2016.05.011  0.414
2016 Skrip LA, Galvani AP. Next Steps for Ebola Vaccination: Deployment in Non-Epidemic, High-Risk Settings. Plos Neglected Tropical Diseases. 10: e0004802. PMID 27537602 DOI: 10.1371/Journal.Pntd.0004802  0.422
2016 Li M, Taylor EG, Atkins KE, Chapman GB, Galvani AP. Stimulating Influenza Vaccination via Prosocial Motives. Plos One. 11: e0159780. PMID 27459237 DOI: 10.1371/Journal.Pone.0159780  0.407
2016 Dolan K, Wirtz AL, Moazen B, Ndeffo-Mbah M, Galvani A, Kinner SA, Courtney R, McKee M, Amon JJ, Maher L, Hellard M, Beyrer C, Altice FL. Global burden of HIV, viral hepatitis, and tuberculosis in prisoners and detainees. Lancet (London, England). PMID 27427453 DOI: 10.1016/S0140-6736(16)30466-4  0.302
2016 Alfaro-Murillo JA, Parpia AS, Fitzpatrick MC, Tamagnan JA, Medlock J, Ndeffo-Mbah ML, Fish D, Ávila-Agüero ML, Marín R, Ko AI, Galvani AP. A Cost-Effectiveness Tool for Informing Policies on Zika Virus Control. Plos Neglected Tropical Diseases. 10: e0004743. PMID 27205899 DOI: 10.1371/Journal.Pntd.0004743  0.306
2016 Atkins KE, Fitzpatrick MC, Galvani AP, Townsend JP. Cost-Effectiveness of Pertussis Vaccination During Pregnancy in the United States. American Journal of Epidemiology. PMID 27188951 DOI: 10.1093/Aje/Kwv347  0.387
2016 Durham DP, Ndeffo-Mbah ML, Skrip LA, Jones FK, Bauch CT, Galvani AP. National- and state-level impact and cost-effectiveness of nonavalent HPV vaccination in the United States. Proceedings of the National Academy of Sciences of the United States of America. PMID 27091978 DOI: 10.1073/Pnas.1515528113  0.378
2016 Fitzpatrick MC, Wenzel NS, Scarpino SV, Althouse BM, Atkins KE, Galvani AP, Townsend JP. Cost-effectiveness of next-generation vaccines: The case of pertussis. Vaccine. PMID 27087151 DOI: 10.1016/J.Vaccine.2016.04.010  0.406
2016 Ndeffo-Mbah ML, Durham DP, Skrip LA, Nsoesie EO, Brownstein JS, Fish D, Galvani AP. Evaluating the effectiveness of localized control strategies to curtail chikungunya. Scientific Reports. 6: 23997. PMID 27045523 DOI: 10.1038/Srep23997  0.392
2016 DeAngelis H, Scarpino SV, Fitzpatrick MC, Galvani AP, Althouse BM. Epidemiological and Economic Effects of Priming With the Whole-Cell Bordetella pertussis Vaccine. Jama Pediatrics. PMID 27018830 DOI: 10.1001/Jamapediatrics.2016.0047  0.387
2016 Gilbert JA, Medlock J, Townsend JP, Aksoy S, Ndeffo Mbah M, Galvani AP. Determinants of Human African Trypanosomiasis Elimination via Paratransgenesis. Plos Neglected Tropical Diseases. 10: e0004465. PMID 26954675 DOI: 10.1371/Journal.Pntd.0004465  0.306
2016 Atkins KE, Pandey A, Wenzel NS, Skrip L, Yamin D, Nyenswah TG, Fallah M, Bawo L, Medlock J, Altice FL, Townsend J, Ndeffo-Mbah ML, Galvani AP. Retrospective Analysis of the 2014-2015 Ebola Epidemic in Liberia. The American Journal of Tropical Medicine and Hygiene. PMID 26928839 DOI: 10.4269/Ajtmh.15-0328  0.362
2016 Parpia AS, Ndeffo-Mbah ML, Wenzel NS, Galvani AP. Effects of Response to 2014-2015 Ebola Outbreak on Deaths from Malaria, HIV/AIDS, and Tuberculosis, West Africa. Emerging Infectious Diseases. 22: 433-41. PMID 26886846 DOI: 10.3201/Eid2203.150977  0.349
2015 Fallah MP, Skrip LA, Gertler S, Yamin D, Galvani AP. Quantifying Poverty as a Driver of Ebola Transmission. Plos Neglected Tropical Diseases. 9: e0004260. PMID 26720278 DOI: 10.1371/Journal.Pntd.0004260  0.336
2015 Hollingsworth TD, Adams ER, Anderson RM, Atkins K, Bartsch S, Basáñez MG, Behrend M, Blok DJ, Chapman LA, Coffeng L, Courtenay O, Crump RE, de Vlas SJ, Dobson A, Dyson L, ... ... Galvani AP, et al. Quantitative analyses and modelling to support achievement of the 2020 goals for nine neglected tropical diseases. Parasites & Vectors. 8: 630. PMID 26652272 DOI: 10.1186/S13071-015-1235-1  0.367
2015 Alfaro-Murillo JA, Townsend JP, Galvani AP. Optimizing age of cytomegalovirus screening and vaccination to avert congenital disease in the US. Vaccine. PMID 26631416 DOI: 10.1016/J.Vaccine.2015.11.039  0.391
2015 Townsend JP, Skrip LA, Galvani AP. Impact of bed capacity on spatiotemporal shifts in Ebola transmission. Proceedings of the National Academy of Sciences of the United States of America. PMID 26518509 DOI: 10.1073/Pnas.1518484112  0.334
2015 Brook CE, Beauclair R, Ngwenya O, Worden L, Ndeffo-Mbah M, Lietman TM, Satpathy SK, Galvani AP, Porco TC. Spatial heterogeneity in projected leprosy trends in India. Parasites & Vectors. 8: 542. PMID 26490137 DOI: 10.1186/S13071-015-1124-7  0.321
2015 Pandey A, Atkins KE, Bucheton B, Camara M, Aksoy S, Galvani AP, Ndeffo-Mbah ML. Evaluating long-term effectiveness of sleeping sickness control measures in Guinea. Parasites & Vectors. 8: 550. PMID 26490037 DOI: 10.1186/S13071-015-1121-X  0.312
2015 Gurarie D, Yoon N, Li E, Ndeffo-Mbah M, Durham D, Phillips AE, Aurelio HO, Ferro J, Galvani AP, King CH. Modelling control of Schistosoma haematobium infection: predictions of the long-term impact of mass drug administration in Africa. Parasites & Vectors. 8: 529. PMID 26489408 DOI: 10.1186/S13071-015-1144-3  0.315
2015 Greenhalgh S, Galvani AP, Medlock J. Disease elimination and re-emergence in differential-equation models. Journal of Theoretical Biology. 387: 174-80. PMID 26471072 DOI: 10.1016/J.Jtbi.2015.09.037  0.319
2015 Ibuka Y, Ohkusa Y, Sugawara T, Chapman GB, Yamin D, Atkins KE, Taniguchi K, Okabe N, Galvani AP. Social contacts, vaccination decisions and influenza in Japan. Journal of Epidemiology and Community Health. PMID 26424846 DOI: 10.1136/Jech-2015-205777  0.385
2015 Fallah M, Skrip LA, D'Harcourt E, Galvani AP. Strategies to prevent future Ebola epidemics The Lancet. 386: 131. PMID 26194388 DOI: 10.1016/S0140-6736(15)61233-8  0.306
2015 Wells C, Yamin D, Ndeffo-Mbah ML, Wenzel N, Gaffney SG, Townsend JP, Meyers LA, Fallah M, Nyenswah TG, Altice FL, Atkins KE, Galvani AP. Correction: Harnessing Case Isolation and Ring Vaccination to Control Ebola. Plos Neglected Tropical Diseases. 9: e0003888. PMID 26107520 DOI: 10.1371/Journal.Pntd.0003888  0.347
2015 Taylor E, Atkins KE, Medlock J, Li M, Chapman G, Galvani AP. Cross-Cultural Household Influence on Vaccination Decisions. Medical Decision Making : An International Journal of the Society For Medical Decision Making. PMID 26085600 DOI: 10.1177/0272989X15591007  0.397
2015 Wells C, Yamin D, Ndeffo-Mbah ML, Wenzel N, Gaffney SG, Townsend JP, Meyers LA, Fallah M, Nyenswah TG, Altice FL, Atkins KE, Galvani AP. Harnessing case isolation and ring vaccination to control ebola. Plos Neglected Tropical Diseases. 9: e0003794. PMID 26024528 DOI: 10.1371/Journal.Pntd.0003794  0.417
2015 Bellan SE, Pulliam JR, Pearson CA, Champredon D, Fox SJ, Skrip L, Galvani AP, Gambhir M, Lopman BA, Porco TC, Meyers LA, Dushoff J. Statistical power and validity of Ebola vaccine trials in Sierra Leone: a simulation study of trial design and analysis. The Lancet. Infectious Diseases. 15: 703-10. PMID 25886798 DOI: 10.1016/S1473-3099(15)70139-8  0.343
2015 Singh B, Huang HC, Morton DP, Johnson GP, Gutfraind A, Galvani AP, Clements B, Meyers LA. Optimizing distribution of pandemic influenza antiviral drugs. Emerging Infectious Diseases. 21: 251-8. PMID 25625858 DOI: 10.3201/Eid2102.141024  0.308
2015 Ndeffo Mbah ML, Parikh S, Galvani AP. Comparing the impact of artemisinin-based combination therapies on malaria transmission in sub-Saharan Africa. The American Journal of Tropical Medicine and Hygiene. 92: 555-60. PMID 25624402 DOI: 10.4269/Ajtmh.14-0490  0.306
2015 Yamin D, Gertler S, Ndeffo-Mbah ML, Skrip LA, Fallah M, Nyenswah TG, Altice FL, Galvani AP. Effect of Ebola progression on transmission and control in Liberia. Annals of Internal Medicine. 162: 11-7. PMID 25347321 DOI: 10.7326/M14-2255  0.319
2014 Lewnard JA, Ndeffo Mbah ML, Alfaro-Murillo JA, Altice FL, Bawo L, Nyenswah TG, Galvani AP. Dynamics and control of Ebola virus transmission in Montserrado, Liberia: a mathematical modelling analysis. The Lancet. Infectious Diseases. 14: 1189-95. PMID 25455986 DOI: 10.1016/S1473-3099(14)70995-8  0.356
2014 Pandey A, Atkins KE, Medlock J, Wenzel N, Townsend JP, Childs JE, Nyenswah TG, Ndeffo-Mbah ML, Galvani AP. Strategies for containing Ebola in West Africa. Science (New York, N.Y.). 346: 991-5. PMID 25414312 DOI: 10.1126/Science.1260612  0.345
2014 Ndeffo Mbah ML, Skrip L, Greenhalgh S, Hotez P, Galvani AP. Impact of Schistosoma mansoni on malaria transmission in Sub-Saharan Africa. Plos Neglected Tropical Diseases. 8: e3234. PMID 25329403 DOI: 10.1371/Journal.Pntd.0003234  0.314
2014 Galvani AP, Ndeffo-Mbah ML, Wenzel N, Childs JE. Ebola vaccination: if not now, when? Annals of Internal Medicine. 161: 749-50. PMID 25141813 DOI: 10.7326/M14-1904  0.381
2014 Yamin D, Balicer RD, Galvani AP. Cost-effectiveness of influenza vaccination in prior pneumonia patients in Israel. Vaccine. 32: 4198-205. PMID 24930716 DOI: 10.1016/J.Vaccine.2014.05.015  0.424
2014 Yamin D, Gavious A, Solnik E, Davidovitch N, Balicer RD, Galvani AP, Pliskin JS. An innovative influenza vaccination policy: targeting last season's patients. Plos Computational Biology. 10: e1003643. PMID 24851863 DOI: 10.1371/Journal.Pcbi.1003643  0.42
2014 Skene KJ, Paltiel AD, Shim E, Galvani AP. A marginal benefit approach for vaccinating influenza "superspreaders". Medical Decision Making : An International Journal of the Society For Medical Decision Making. 34: 536-49. PMID 24740238 DOI: 10.1177/0272989X14523502  0.376
2014 Gilbert JA, Meyers LA, Galvani AP, Townsend JP. Probabilistic uncertainty analysis of epidemiological modeling to guide public health intervention policy. Epidemics. 6: 37-45. PMID 24593920 DOI: 10.1016/J.Epidem.2013.11.002  0.354
2014 Fitzpatrick MC, Hampson K, Cleaveland S, Mzimbiri I, Lankester F, Lembo T, Meyers LA, Paltiel AD, Galvani AP. Cost-effectiveness of canine vaccination to prevent human rabies in rural Tanzania. Annals of Internal Medicine. 160: 91-100. PMID 24592494 DOI: 10.7326/M13-0542  0.38
2014 Ibuka Y, Li M, Vietri J, Chapman GB, Galvani AP. Free-riding behavior in vaccination decisions: an experimental study. Plos One. 9: e87164. PMID 24475246 DOI: 10.1371/Journal.Pone.0087164  0.397
2014 Ndeffo Mbah ML, Durham DP, Medlock J, Galvani AP. Country- and age-specific optimal allocation of dengue vaccines. Journal of Theoretical Biology. 342: 15-22. PMID 24161462 DOI: 10.1016/J.Jtbi.2013.10.006  0.406
2014 Wells CR, Tchuenche JM, Meyers LA, Galvani AP, Bauch CT. Erratum to: Impact of Imitation Processes on the Effectiveness of Ring Vaccination Bulletin of Mathematical Biology. 76: 2941-2944. DOI: 10.1007/S11538-014-0008-X  0.352
2013 Boni MF, Galvani AP, Wickelgren AL, Malani A. Economic epidemiology of avian influenza on smallholder poultry farms. Theoretical Population Biology. 90: 135-44. PMID 24161559 DOI: 10.1016/J.Tpb.2013.10.001  0.322
2013 Bauch CT, Galvani AP. Epidemiology. Social factors in epidemiology. Science (New York, N.Y.). 342: 47-9. PMID 24092718 DOI: 10.1126/Science.1244492  0.417
2013 Medlock J, Atkins KE, Thomas DN, Aksoy S, Galvani AP. Evaluating paratransgenesis as a potential control strategy for African trypanosomiasis. Plos Neglected Tropical Diseases. 7: e2374. PMID 23967363 DOI: 10.1371/Journal.Pntd.0002374  0.338
2013 Aksoy S, Caccone A, Galvani AP, Okedi LM. Glossina fuscipes populations provide insights for human African trypanosomiasis transmission in Uganda. Trends in Parasitology. 29: 394-406. PMID 23845311 DOI: 10.1016/J.Pt.2013.06.005  0.305
2013 Durham DP, Ndeffo Mbah ML, Medlock J, Luz PM, Meyers LA, Paltiel AD, Galvani AP. Dengue dynamics and vaccine cost-effectiveness in Brazil. Vaccine. 31: 3957-61. PMID 23791696 DOI: 10.1016/J.Vaccine.2013.06.036  0.618
2013 Ndeffo Mbah ML, Medlock J, Meyers LA, Galvani AP, Townsend JP. Optimal targeting of seasonal influenza vaccination toward younger ages is robust to parameter uncertainty. Vaccine. 31: 3079-89. PMID 23684837 DOI: 10.1016/J.Vaccine.2013.04.052  0.41
2013 Ndeffo Mbah ML, Kjetland EF, Atkins KE, Poolman EM, Orenstein EW, Meyers LA, Townsend JP, Galvani AP. Cost-effectiveness of a community-based intervention for reducing the transmission of Schistosoma haematobium and HIV in Africa. Proceedings of the National Academy of Sciences of the United States of America. 110: 7952-7. PMID 23589884 DOI: 10.1073/Pnas.1221396110  0.332
2013 Yamin D, Remy V, Atkins KE, Galvani AP. What Clinical Benefits Could Be Expected from the Implementation of a Rotavirus Vaccination Programme in France Value in Health. 16. DOI: 10.1016/J.Jval.2013.08.220  0.37
2012 Tekle YI, Nielsen KM, Liu J, Pettigrew MM, Meyers LA, Galvani AP, Townsend JP. Controlling antimicrobial resistance through targeted, vaccine-induced replacement of strains. Plos One. 7: e50688. PMID 23227198 DOI: 10.1371/Journal.Pone.0050688  0.42
2012 Atkins KE, Shim E, Carroll S, Quilici S, Galvani AP. The cost-effectiveness of pentavalent rotavirus vaccination in England and Wales. Vaccine. 30: 6766-76. PMID 23000223 DOI: 10.1016/J.Vaccine.2012.09.025  0.41
2012 Shim E, Galvani AP. Distinguishing vaccine efficacy and effectiveness. Vaccine. 30: 6700-5. PMID 22944629 DOI: 10.1016/J.Vaccine.2012.08.045  0.403
2012 Fitzpatrick MC, Hampson K, Cleaveland S, Meyers LA, Townsend JP, Galvani AP. Potential for rabies control through dog vaccination in wildlife-abundant communities of Tanzania. Plos Neglected Tropical Diseases. 6: e1796. PMID 22928056 DOI: 10.1371/Journal.Pntd.0001796  0.426
2012 Pitzer VE, Atkins KE, de Blasio BF, Van Effelterre T, Atchison CJ, Harris JP, Shim E, Galvani AP, Edmunds WJ, Viboud C, Patel MM, Grenfell BT, Parashar UD, Lopman BA. Direct and indirect effects of rotavirus vaccination: comparing predictions from transmission dynamic models. Plos One. 7: e42320. PMID 22912699 DOI: 10.1371/Journal.Pone.0042320  0.418
2012 Chapman GB, Li M, Vietri J, Ibuka Y, Thomas D, Yoon H, Galvani AP. Using game theory to examine incentives in influenza vaccination behavior. Psychological Science. 23: 1008-15. PMID 22810166 DOI: 10.1177/0956797612437606  0.388
2012 Araz OM, Galvani A, Meyers LA. Geographic prioritization of distributing pandemic influenza vaccines. Health Care Management Science. 15: 175-87. PMID 22618029 DOI: 10.1007/S10729-012-9199-6  0.382
2012 Ndeffo Mbah ML, Liu J, Bauch CT, Tekel YI, Medlock J, Meyers LA, Galvani AP. The impact of imitation on vaccination behavior in social contact networks. Plos Computational Biology. 8: e1002469. PMID 22511859 DOI: 10.1371/Journal.Pcbi.1002469  0.394
2012 Shim E, Chapman GB, Townsend JP, Galvani AP. The influence of altruism on influenza vaccination decisions. Journal of the Royal Society, Interface / the Royal Society. 9: 2234-43. PMID 22496100 DOI: 10.1098/Rsif.2012.0115  0.398
2012 Ibuka Y, Paltiel AD, Galvani AP. Impact of program scale and indirect effects on the cost-effectiveness of vaccination programs. Medical Decision Making : An International Journal of the Society For Medical Decision Making. 32: 442-6. PMID 22472916 DOI: 10.1177/0272989X12441397  0.314
2012 Tsao K, Fish D, Galvani AP. Predicted outcomes of vaccinating wildlife to reduce human risk of Lyme disease. Vector Borne and Zoonotic Diseases (Larchmont, N.Y.). 12: 544-51. PMID 22251312 DOI: 10.1089/Vbz.2011.0731  0.418
2012 Atkins KE, Shim E, Pitzer VE, Galvani AP. Impact of rotavirus vaccination on epidemiological dynamics in England and Wales. Vaccine. 30: 552-64. PMID 22133508 DOI: 10.1016/J.Vaccine.2011.11.064  0.413
2012 Vietri JT, Li M, Galvani AP, Chapman GB. Vaccinating to help ourselves and others. Medical Decision Making : An International Journal of the Society For Medical Decision Making. 32: 447-58. PMID 22127841 DOI: 10.1177/0272989X11427762  0.397
2012 Tully SP, Anonychuk AM, Sanchez DM, Galvani AP, Bauch CT. Time for change? An economic evaluation of integrated cervical screening and HPV immunization programs in Canada. Vaccine. 30: 425-35. PMID 22075091 DOI: 10.1016/J.Vaccine.2011.10.067  0.315
2012 Li M, Chapman GB, Ibuka Y, Meyers LA, Galvani A. Who got vaccinated against H1N1 pandemic influenza? A longitudinal study in four U.S. cities. Psychology & Health. 27: 101-15. PMID 21736427 DOI: 10.1080/08870446.2011.554833  0.393
2012 Liu J, Kochin BF, Tekle YI, Galvani AP. Epidemiological game-theory dynamics of chickenpox vaccination in the USA and Israel. Journal of the Royal Society, Interface / the Royal Society. 9: 68-76. PMID 21632611 DOI: 10.1098/Rsif.2011.0001  0.407
2011 Alam U, Medlock J, Brelsfoard C, Pais R, Lohs C, Balmand S, Carnogursky J, Heddi A, Takac P, Galvani A, Aksoy S. Wolbachia symbiont infections induce strong cytoplasmic incompatibility in the tsetse fly Glossina morsitans. Plos Pathogens. 7: e1002415. PMID 22174680 DOI: 10.1371/Journal.Ppat.1002415  0.328
2011 Luz PM, Vanni T, Medlock J, Paltiel AD, Galvani AP. Dengue vector control strategies in an urban setting: an economic modelling assessment. Lancet (London, England). 377: 1673-80. PMID 21546076 DOI: 10.1016/S0140-6736(11)60246-8  0.585
2011 Wells CR, Tchuenche JM, Meyers LA, Galvani AP, Bauch CT. Impact of imitation processes on the effectiveness of ring vaccination. Bulletin of Mathematical Biology. 73: 2748-72. PMID 21409511 DOI: 10.1007/S11538-011-9646-4  0.406
2011 Shim E, Meyers LA, Galvani AP. Optimal H1N1 vaccination strategies based on self-interest versus group interest. Bmc Public Health. 11: S4. PMID 21356133 DOI: 10.1186/1471-2458-11-S1-S4  0.417
2011 Cornforth DM, Reluga TC, Shim E, Bauch CT, Galvani AP, Meyers LA. Erratic flu vaccination emerges from short-sighted behavior in contact networks. Plos Computational Biology. 7: e1001062. PMID 21298083 DOI: 10.1371/Journal.Pcbi.1001062  0.407
2011 Reluga TC, Galvani AP. A general approach for population games with application to vaccination. Mathematical Biosciences. 230: 67-78. PMID 21277314 DOI: 10.1016/J.Mbs.2011.01.003  0.376
2011 Atkins KE, Shim E, Carroll S, Quilici S, Galvani AP. PIN70 Modelling the Epidemiological Impact of Rotavirus Vaccination to Assess its Cost-Effectiveness in England and Wales Value in Health. 14. DOI: 10.1016/J.Jval.2011.08.256  0.392
2010 Luz PM, Struchiner CJ, Galvani AP. Modeling transmission dynamics and control of vector-borne neglected tropical diseases. Plos Neglected Tropical Diseases. 4: e761. PMID 21049062 DOI: 10.1371/Journal.Pntd.0000761  0.582
2010 Ibuka Y, Chapman GB, Meyers LA, Li M, Galvani AP. The dynamics of risk perceptions and precautionary behavior in response to 2009 (H1N1) pandemic influenza. Bmc Infectious Diseases. 10: 296. PMID 20946662 DOI: 10.1186/1471-2334-10-296  0.305
2010 Shim E, Chapman GB, Galvani AP. Decision making with regard to antiviral intervention during an influenza pandemic. Medical Decision Making : An International Journal of the Society For Medical Decision Making. 30: E64-81. PMID 20634545 DOI: 10.1177/0272989X10374112  0.341
2010 Bauch CT, Li M, Chapman G, Galvani AP. Adherence to cervical screening in the era of human papillomavirus vaccination: how low is too low? The Lancet. Infectious Diseases. 10: 133-7. PMID 20113982 DOI: 10.1016/S1473-3099(10)70004-9  0.378
2009 Medlock J, Meyers LA, Galvani A. Optimizing allocation for a delayed influenza vaccination campaign. Plos Currents. 1: RRN1134. PMID 20033093 DOI: 10.1371/Currents.Rrn1134  0.408
2009 Shim E, Hampson K, Cleaveland S, Galvani AP. Evaluating the cost-effectiveness of rabies post-exposure prophylaxis: a case study in Tanzania. Vaccine. 27: 7167-72. PMID 19925948 DOI: 10.1016/J.Vaccine.2009.09.027  0.357
2009 Shim E, Kochin B, Galvani A. Insights from epidemiological game theory into gender-specific vaccination against rubella Mathematical Biosciences and Engineering. 6: 839-854. PMID 19835431 DOI: 10.3934/Mbe.2009.6.839  0.409
2009 Medlock J, Luz PM, Struchiner CJ, Galvani AP. The impact of transgenic mosquitoes on dengue virulence to humans and mosquitoes. The American Naturalist. 174: 565-77. PMID 19737112 DOI: 10.1086/605403  0.588
2009 Medlock J, Galvani AP. Optimizing influenza vaccine distribution. Science (New York, N.Y.). 325: 1705-8. PMID 19696313 DOI: 10.1126/Science.1175570  0.412
2009 Shim E, Galvani AP. Evolutionary repercussions of avian culling on host resistance and influenza virulence. Plos One. 4: e5503. PMID 19430529 DOI: 10.1371/Journal.Pone.0005503  0.325
2009 Shim E, Galvani AP. Impact of transmission dynamics on the cost-effectiveness of rotavirus vaccination. Vaccine. 27: 4025-30. PMID 19389452 DOI: 10.1016/J.Vaccine.2009.04.030  0.403
2009 Basu S, Friedland GH, Medlock J, Andrews JR, Shah NS, Gandhi NR, Moll A, Moodley P, Sturm AW, Galvani AP. Averting epidemics of extensively drug-resistant tuberculosis. Proceedings of the National Academy of Sciences of the United States of America. 106: 7672-7. PMID 19365076 DOI: 10.1073/Pnas.0812472106  0.492
2009 Orenstein EW, Basu S, Shah NS, Andrews JR, Friedland GH, Moll AP, Gandhi NR, Galvani AP. Treatment outcomes among patients with multidrug-resistant tuberculosis: systematic review and meta-analysis. The Lancet. Infectious Diseases. 9: 153-61. PMID 19246019 DOI: 10.1016/S1473-3099(09)70041-6  0.452
2009 Basu S, Galvani AP. The evolution of tuberculosis virulence. Bulletin of Mathematical Biology. 71: 1073-88. PMID 19172358 DOI: 10.1007/S11538-009-9394-X  0.483
2009 Luz PM, Grinsztejn B, Galvani AP. Disability adjusted life years lost to dengue in Brazil. Tropical Medicine & International Health : Tm & Ih. 14: 237-46. PMID 19171013 DOI: 10.1111/J.1365-3156.2008.02203.X  0.582
2009 Luz PM, Codeço CT, Medlock J, Struchiner CJ, Valle D, Galvani AP. Impact of insecticide interventions on the abundance and resistance profile of Aedes aegypti. Epidemiology and Infection. 137: 1203-15. PMID 19134235 DOI: 10.1017/S0950268808001799  0.562
2009 Medlock J, Galvani AP. Protecting the Herd from H1N1—Response Science. 326: 934-934. DOI: 10.1126/Science.326.5955.934-B  0.34
2008 Luz PM, Mendes BV, Codeço CT, Struchiner CJ, Galvani AP. Time series analysis of dengue incidence in Rio de Janeiro, Brazil. The American Journal of Tropical Medicine and Hygiene. 79: 933-9. PMID 19052308 DOI: 10.4269/Ajtmh.2008.79.933  0.555
2008 Basu S, Chapman GB, Galvani AP. Integrating epidemiology, psychology, and economics to achieve HPV vaccination targets. Proceedings of the National Academy of Sciences of the United States of America. 105: 19018-23. PMID 19015536 DOI: 10.1073/Pnas.0808114105  0.541
2008 Basu S, Orenstein E, Galvani AP. The theoretical influence of immunity between strain groups on the progression of drug-resistant tuberculosis epidemics. The Journal of Infectious Diseases. 198: 1502-13. PMID 18816192 DOI: 10.1086/592508  0.47
2008 Poolman EM, Elbasha EH, Galvani AP. Vaccination and the evolutionary ecology of human papillomavirus. Vaccine. 26: C25-30. PMID 18773535 DOI: 10.1016/J.Vaccine.2008.04.010  0.361
2008 Day T, Galvani A, Struchiner C, Gumel A. The evolutionary consequences of vaccination. Vaccine. 26: C1-3. PMID 18773533 DOI: 10.1016/J.Vaccine.2008.02.006  0.376
2008 Basu S, Galvani AP. The transmission and control of XDR TB in South Africa: an operations research and mathematical modelling approach. Epidemiology and Infection. 136: 1585-98. PMID 18606028 DOI: 10.1017/S0950268808000964  0.499
2008 Hu C, Rio RV, Medlock J, Haines LR, Nayduch D, Savage AF, Guz N, Attardo GM, Pearson TW, Galvani AP, Aksoy S. Infections with immunogenic trypanosomes reduce tsetse reproductive fitness: potential impact of different parasite strains on vector population structure. Plos Neglected Tropical Diseases. 2: e192. PMID 18335067 DOI: 10.1371/Journal.Pntd.0000192  0.322
2007 Basu S, Andrews JR, Poolman EM, Gandhi NR, Shah NS, Moll A, Moodley P, Galvani AP, Friedland GH. Prevention of nosocomial transmission of extensively drug-resistant tuberculosis in rural South African district hospitals: an epidemiological modelling study. Lancet (London, England). 370: 1500-7. PMID 17964351 DOI: 10.1016/S0140-6736(07)61636-5  0.517
2007 Basu S, Galvani AP. Re: "Multiparameter calibration of a natural history model of cervical cancer". American Journal of Epidemiology. 166: 983; author reply 98. PMID 17728268 DOI: 10.1093/Aje/Kwm240  0.413
2007 Reluga TC, Medlock J, Poolman E, Galvani AP. Optimal timing of disease transmission in an age-structured population. Bulletin of Mathematical Biology. 69: 2711-22. PMID 17701261 DOI: 10.1007/S11538-007-9238-5  0.305
2007 Codeço CT, Luz PM, Coelho F, Galvani AP, Struchiner C. Vaccinating in disease-free regions: a vaccine model with application to yellow fever. Journal of the Royal Society, Interface / the Royal Society. 4: 1119-25. PMID 17442650 DOI: 10.1098/Rsif.2007.0234  0.633
2007 Galvani AP, Reluga TC, Chapman GB. Long-standing influenza vaccination policy is in accord with individual self-interest but not with the utilitarian optimum. Proceedings of the National Academy of Sciences of the United States of America. 104: 5692-7. PMID 17369367 DOI: 10.1073/Pnas.0606774104  0.413
2007 Basu S, Galvani AP. Extensively drug-resistant tuberculosis in South Africa. Lancet (London, England). 369: 272-3. PMID 17258662 DOI: 10.1016/S0140-6736(07)60143-3  0.367
2006 Poolman EM, Galvani AP. Modeling targeted ivermectin treatment for controlling river blindness. The American Journal of Tropical Medicine and Hygiene. 75: 921-7. PMID 17123988 DOI: 10.4269/Ajtmh.2006.75.921  0.326
2006 Reluga TC, Bauch CT, Galvani AP. Evolving public perceptions and stability in vaccine uptake. Mathematical Biosciences. 204: 185-98. PMID 17056073 DOI: 10.1016/J.Mbs.2006.08.015  0.41
2006 Reluga TC, Medlock J, Galvani AP. A model of spatial epidemic spread when individuals move within overlapping home ranges. Bulletin of Mathematical Biology. 68: 401-16. PMID 16794937 DOI: 10.1007/S11538-005-9027-Y  0.307
2005 Galvani AP, May RM. Epidemiology: dimensions of superspreading. Nature. 438: 293-5. PMID 16292292 DOI: 10.1038/438293A  0.314
2005 Bauch CT, Lloyd-Smith JO, Coffee MP, Galvani AP. Dynamically modeling SARS and other newly emerging respiratory illnesses: past, present, and future. Epidemiology (Cambridge, Mass.). 16: 791-801. PMID 16222170 DOI: 10.1097/01.Ede.0000181633.80269.4C  0.317
2005 Elbasha EH, Galvani AP. Vaccination against multiple HPV types. Mathematical Biosciences. 197: 88-117. PMID 16095627 DOI: 10.2307/27646309  0.305
2005 Galvani AP. Age-dependent epidemiological patterns and strain diversity in helminth parasites. The Journal of Parasitology. 91: 24-30. PMID 15856867 DOI: 10.1645/Ge-191R1  0.313
2005 Porco TC, Lloyd-Smith JO, Gross KL, Galvani AP. The effect of treatment on pathogen virulence. Journal of Theoretical Biology. 233: 91-102. PMID 15615623 DOI: 10.1016/J.Jtbi.2004.09.009  0.31
2004 Galvani AP. Emerging infections: what have we learned from SARS? Emerging Infectious Diseases. 10: 1351-1352. PMID 15338569 DOI: 10.3201/Eid1007.040166  0.407
2003 Bauch CT, Galvani AP, Earn DJD. Group interest versus self-interest in smallpox vaccination policy Proceedings of the National Academy of Sciences of the United States of America. 100: 10564-10567. PMID 12920181 DOI: 10.1073/Pnas.1731324100  0.379
2003 Ferguson NM, Galvani AP, Bush RM. Ecological and immunological determinants of influenza evolution. Nature. 422: 428-33. PMID 12660783 DOI: 10.1038/Nature01509  0.361
2003 Galvani AP. Epidemiology meets evolutionary ecology Trends in Ecology and Evolution. 18: 132-139. DOI: 10.1016/S0169-5347(02)00050-2  0.329
Show low-probability matches.